Published Online
on May 2, 2005

A more recent version of this article appeared on May 17, 2005

This Article Full Text (PDF) All Versions of this Article: 111/19/2494    most recent 01.CIR.0000165117.71483.0Cv1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, M. Articles by Wang, Y. Search for Related Content PubMed PubMed Citation Articles by Li, M. Articles by Wang, Y. Related Collections Congestive Animal models of human disease Physiological and pathological control of gene expression

Submitted on September 20, 2004
Revised on December 6, 2004
Accepted on December 21, 2004

p38 MAP Kinase Mediates Inflammatory Cytokine Induction in Cardiomyocytes and Extracellular Matrix Remodeling in Heart

Manxiang Li MD, PhD, Dimitrios Georgakopoulos PhD, Gang Lu MS, Lisa Hester BA, David A. Kass MD, PhD, Jeffery Hasday MD, and Yibin Wang PhD^*

From the Departments of Physiology (M.L., Y.W.) and Medicine (L.H., J.H.), University of Maryland, School of Medicine, Baltimore; Department of Medicine, Johns Hopkins University, Baltimore, Md (D.G., D.A.K.); and Division of Molecular Medicine, Departments of Anesthesiology and Medicine, Molecular Biology Institute, David Geffen School of Medicine, University of California at Los Angeles (G.L., Y.W.).

^* To whom correspondence should be addressed. E-mail: yibinwang{at}mednet.ucla.edu.

Background--Increasing evidence suggests that development of heart failure involves activation of stress-response inflammatory cytokines, including tumor necrosis factor- and interleukin-6. Yet, the myocyte contribution to their induction in failing hearts and the underlying regulatory mechanism in stressed myocardium remain unclear.

Methods and Results--In cultured cardiac myocytes, specific activation of stress-activated mitogen-activated protein kinase, p38, by upstream activator MKK6bE led to significant induction of tumor necrosis factor- and interleukin-6 secretion, whereas treating cells with a selective p38 inhibitor (SB239068) significantly blocked the cytokine secretion from myocytes and increased their intracellular accumulation. Targeted expression of MKK6bE in transgenic hearts also resulted in a marked elevation in plasma tumor necrosis factor- and interleukin-6; oral administration of SB239068 resulted in a significant reduction in their plasma levels but an increase in intracardiac accumulation of both cytokines. MKK6bE transgenic hearts developed marked interstitial fibrosis with increased matrix metalloproteinase abundance and selective induction of tissue inhibitor of matrix metalloproteinase-1; this extracellular matrix remodeling was also significantly attenuated by p38 inhibition. Along with cytokine induction and extracellular remodeling, MKK6bE transgenic animals displayed impaired hemodynamic function, whereas p38 inhibition improved the cardiac performance and prolonged the survival of the animals.

Conclusions--Stress-activated p38 kinase is a critical regulator of inflammatory response in cardiomyocytes with significant contribution to pathological remodeling in stressed myocardium. Inhibition of p38 may represent a useful therapeutic avenue to ameliorate cardiac pathology and heart failure evolution.

Key words: inflammation • cardiomyopathy • signal transduction • heart failure

This article has been cited by other articles:

				B. M. Proctor, X. Jin, T. S. Lupu, L. J. Muglia, C. F. Semenkovich, and A. J. Muslin Requirement for p38 Mitogen-Activated Protein Kinase Activity in Neointima Formation After Vascular Injury Circulation, August 5, 2008; 118(6): 658 - 666. [Abstract] [Full Text] [PDF]

				A. R. Kompa, F. See, D. A. Lewis, A. Adrahtas, D. M. Cantwell, B. H. Wang, and H. Krum Long-Term but Not Short-Term p38 Mitogen-Activated Protein Kinase Inhibition Improves Cardiac Function and Reduces Cardiac Remodeling Post-Myocardial Infarction J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 741 - 750. [Abstract] [Full Text] [PDF]

				M. Yang, J. Wu, C. M. Martin, P. R. Kvietys, and T. Rui Important role of p38 MAP kinase/NF-{kappa}B signaling pathway in the sepsis-induced conversion of cardiac myocytes to a proinflammatory phenotype Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H994 - H1001. [Abstract] [Full Text] [PDF]

				B.-W. Wang, H.-F. Hung, H. Chang, P. Kuan, and K.-G. Shyu Mechanical stretch enhances the expression of resistin gene in cultured cardiomyocytes via tumor necrosis factor-{alpha} Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2305 - H2312. [Abstract] [Full Text] [PDF]

				Y. Wang Mitogen-Activated Protein Kinases in Heart Development and Diseases Circulation, September 18, 2007; 116(12): 1413 - 1423. [Abstract] [Full Text] [PDF]

				M. Odashima, S. Usui, H. Takagi, C. Hong, J. Liu, M. Yokota, and J. Sadoshima Inhibition of Endogenous Mst1 Prevents Apoptosis and Cardiac Dysfunction Without Affecting Cardiac Hypertrophy After Myocardial Infarction Circ. Res., May 11, 2007; 100(9): 1344 - 1352. [Abstract] [Full Text] [PDF]

				J. Chao, H.-J. Li, Y.-Y. Yao, B. Shen, L. Gao, G. Bledsoe, and L. Chao Kinin Infusion Prevents Renal Inflammation, Apoptosis, and Fibrosis via Inhibition of Oxidative Stress and Mitogen-Activated Protein Kinase Activity Hypertension, March 1, 2007; 49(3): 490 - 497. [Abstract] [Full Text] [PDF]

				O. Tenhunen, J. Rysa, M. Ilves, Y. Soini, H. Ruskoaho, and H. Leskinen Identification of Cell Cycle Regulatory and Inflammatory Genes As Predominant Targets of p38 Mitogen-Activated Protein Kinase in the Heart Circ. Res., September 1, 2006; 99(5): 485 - 493. [Abstract] [Full Text] [PDF]

				M. Bellahcene, S. Jacquet, X. B. Cao, M. Tanno, R. S. Haworth, J. Layland, A. M. Kabir, M. Gaestel, R. J. Davis, R. A. Flavell, et al. Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Early Cardiodepressant Action of Tumor Necrosis Factor J. Am. Coll. Cardiol., August 1, 2006; 48(3): 545 - 555. [Abstract] [Full Text] [PDF]

				C. Ballard-Croft, A. C. Locklar, G. Kristo, and R. D. Lasley Regional myocardial ischemia-induced activation of MAPKs is associated with subcellular redistribution of caveolin and cholesterol Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H658 - H667. [Abstract] [Full Text] [PDF]

				E. A. Jankowska, P. Ponikowski, M. F. Piepoli, W. Banasiak, S. D. Anker, and P. A. Poole-Wilson Autonomic imbalance and immune activation in chronic heart failure - Pathophysiological links Cardiovasc Res, June 1, 2006; 70(3): 434 - 445. [Abstract] [Full Text] [PDF]

				C. M. Filipeanu, F. Zhou, E. K. Fugetta, and G. Wu Differential Regulation of the Cell-Surface Targeting and Function of beta- and {alpha}1-Adrenergic Receptors by Rab1 GTPase in Cardiac Myocytes Mol. Pharmacol., May 1, 2006; 69(5): 1571 - 1578. [Abstract] [Full Text] [PDF]

				S. Mitchell, A. Ota, W. Foster, B. Zhang, Z. Fang, S. Patel, S. F. Nelson, S. Horvath, and Y. Wang Distinct gene expression profiles in adult mouse heart following targeted MAP kinase activation Physiol Genomics, March 13, 2006; 25(1): 50 - 59. [Abstract] [Full Text] [PDF]

				G. Lu, Y. J. Kang, J. Han, H. R. Herschman, E. Stefani, and Y. Wang TAB-1 Modulates Intracellular Localization of p38 MAP Kinase and Downstream Signaling J. Biol. Chem., March 3, 2006; 281(9): 6087 - 6095. [Abstract] [Full Text] [PDF]